Innovate Thyroid Eye Disease 2024 Multidisciplinary Symposium-April 26-28, 2024, Napa, California.

Competing Interests: C.D.: member of the Sling Therapeutics Scientific Advisory Board; consultant for Amgen/Horizon, Immunovant, and Third Rock Ventures; performs research with Viridian Therapeutics and Sling Therapeutics. M.S.: his institution received grants from Immunovant, Viridian, Sling and Lassen; and he received consulting fees from Third Rock Ventures, Septerna, Grifols, Tshaka Bio, MingHui Pharma, Lundbeck, Lasses, Tourmaline, Avilar, Genentech, and ArgenX. A.L.K.: consultant/advisor for Amgen/Horizon Therapeutics, Immunovant Inc., Aceylrin, Kriya Therapeutics, Viridian Therapeutics, Lassen Therapeutics, Genentech, and Argenx; performs research with Sling Therapeutics, Amgen/Horizon Therapeutics, Kriya Therapeutics, Viridian Therapeutics, and Lassen Therapeutics. M.K. has no financial or conflicts of interest to disclose.